HK1220113A1 - 药物软明胶胶囊剂型 - Google Patents

药物软明胶胶囊剂型 Download PDF

Info

Publication number
HK1220113A1
HK1220113A1 HK16108115.5A HK16108115A HK1220113A1 HK 1220113 A1 HK1220113 A1 HK 1220113A1 HK 16108115 A HK16108115 A HK 16108115A HK 1220113 A1 HK1220113 A1 HK 1220113A1
Authority
HK
Hong Kong
Prior art keywords
dosage form
gelatin capsule
soft gelatin
capsule dosage
pharmaceutical soft
Prior art date
Application number
HK16108115.5A
Other languages
English (en)
Chinese (zh)
Inventor
Brendan Muldoon
Stephen Mccullagh
Original Assignee
Warner Chilcott Company, Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Chilcott Company, Llc filed Critical Warner Chilcott Company, Llc
Publication of HK1220113A1 publication Critical patent/HK1220113A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A61K9/4825—Proteins, e.g. gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HK16108115.5A 2013-03-15 2014-03-14 药物软明胶胶囊剂型 HK1220113A1 (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361794813P 2013-03-15 2013-03-15
US61/794,813 2013-03-15
PCT/US2014/027093 WO2014152226A1 (en) 2013-03-15 2014-03-14 Pharmaceutical soft gelatin capsule dosage form

Publications (1)

Publication Number Publication Date
HK1220113A1 true HK1220113A1 (zh) 2017-04-28

Family

ID=50391548

Family Applications (1)

Application Number Title Priority Date Filing Date
HK16108115.5A HK1220113A1 (zh) 2013-03-15 2014-03-14 药物软明胶胶囊剂型

Country Status (11)

Country Link
US (1) US20140271837A1 (enExample)
EP (1) EP2968183B1 (enExample)
JP (1) JP6335269B2 (enExample)
CN (1) CN105392476B (enExample)
AU (1) AU2014240039B2 (enExample)
CA (1) CA2906619C (enExample)
ES (1) ES2681982T3 (enExample)
HK (1) HK1220113A1 (enExample)
IL (1) IL242438B (enExample)
MX (1) MX376951B (enExample)
WO (1) WO2014152226A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3031628B2 (ja) 1990-04-07 2000-04-10 株式会社日立製作所 洗濯乾燥機
JP3143355B2 (ja) 1995-03-28 2001-03-07 三洋電機株式会社 遠心脱水装置
US10673199B2 (en) 2016-09-29 2020-06-02 Nlight, Inc. Fiber-based saturable absorber
US10673198B2 (en) 2016-09-29 2020-06-02 Nlight, Inc. Fiber-coupled laser with time varying beam characteristics
US10673197B2 (en) 2016-09-29 2020-06-02 Nlight, Inc. Fiber-based optical modulator
KR20230107647A (ko) * 2020-11-13 2023-07-17 화이자 인코포레이티드 탈라조파립 연질 젤라틴 캡슐 투여 형태

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK242083D0 (da) * 1983-05-27 1983-05-27 Hansens Chr Bio Syst Vaginalkapsler
US5102666A (en) * 1990-09-11 1992-04-07 Oramed, Inc. Calcium polycarbophil controlled release composition and method
IT1275816B1 (it) * 1995-10-27 1997-10-17 Montefarmaco Spa Composizioni farmaceutiche solide per uso vaginale
WO1997033568A1 (en) 1996-03-12 1997-09-18 Novartis Ag Filled gelatin capsules having a reduced degree of cross-linking
US20040131670A1 (en) * 2001-04-17 2004-07-08 Ping Gao Pellicle-resistant gelatin capsule
EP1709061A1 (en) 2004-01-15 2006-10-11 Warner Chilcott Company Inc. Di-steroidal prodrugs of ethinyl estradiol
WO2005070949A1 (en) 2004-01-15 2005-08-04 Warner Chilcott Company, Inc. Di-steroidal prodrugs of estradiol
US10016442B2 (en) 2005-06-16 2018-07-10 Allergan Pharmaceuticals International Limited Estrogen compositions for vaginal administration
CA2610481A1 (en) 2005-07-12 2007-01-18 Warner Chilcott Company, Inc. 3-ester prodrugs of estradiol
CN101218245B (zh) 2005-07-12 2011-08-17 沃纳奇尔科特有限责任公司 炔雌醇的3-酯前药
CN101360485B (zh) * 2005-10-26 2013-04-17 班纳制药公司 作为胶囊填充物的基于亲水性载体的双重控释基质系统
US20070104778A1 (en) * 2005-11-07 2007-05-10 Hongxia Zeng Controlled-release emulsion compositions
EP2011496A1 (en) * 2007-07-03 2009-01-07 Indena S.P.A. Combinations of vasoactive substances with estrogens and their use in the treatment of female sexual dysfunctions

Also Published As

Publication number Publication date
EP2968183A1 (en) 2016-01-20
IL242438B (en) 2020-01-30
JP2016513680A (ja) 2016-05-16
CN105392476B (zh) 2018-11-02
JP6335269B2 (ja) 2018-05-30
CA2906619A1 (en) 2014-09-25
CA2906619C (en) 2021-11-16
AU2014240039B2 (en) 2019-01-24
EP2968183B1 (en) 2018-05-09
MX376951B (es) 2025-03-07
MX2015012075A (es) 2016-05-10
US20140271837A1 (en) 2014-09-18
AU2014240039A1 (en) 2015-10-15
CN105392476A (zh) 2016-03-09
ES2681982T3 (es) 2018-09-17
WO2014152226A1 (en) 2014-09-25

Similar Documents

Publication Publication Date Title
HK1220113A1 (zh) 药物软明胶胶囊剂型
MX2019007956A (es) Liberacion autorregulada de ingrediente farmaceutico activo.
CL2015000893A1 (es) Formulación de una forma farmacéutica sólida de desintegración rápida que comprende carbonato de calcio funcionalizado, un ingrediente activo y por lo menos un desintegrante; y método para su fabricación.
EA201691193A1 (ru) Система доставки лекарственных средств
WO2015184127A3 (en) Stable cannabinoid formulations
UY35351A (es) Formulaciones acuosas estables de adalimumab
MX380566B (es) Composición oral que comprende una primera población de microesferas con un ingrediente activo susceptible o con potencial de abuso y una segunda población de microesferas con óxido de polietileno y un recubrimiento permeable o semipermeable.
CL2017003437A1 (es) Formulación solida oral que contiene irinotecán y método de preparación de la misma
UY35859A (es) ?combinación farmacéutica que comprende amlodipina, losartán y rosuvastatina?.
EA201690679A1 (ru) Стабильная фармацевтическая композиция, содержащая амлодипин и валсартан
WO2014114255A3 (zh) 一种定位速释生物粘附剂及应用
MX2019004554A (es) Forma de dosis farmaceutica de capsula de gelatina blanda con goma guar modificada.
PH12014502856B1 (en) Solid pharmaceutical preparation containing levothyroxine
EA201400737A1 (ru) Система доставки на основе множества пеллет с немедленным высвобождением активного вещества
PH12015000297B1 (en) Pharmaceutical combination preparation
MX368363B (es) Forma de dosificacion efervescente.
SI3060203T1 (en) A effervescent tablet containing a high level of aspirin
EP3216450A8 (en) Pharmaceutical preparation comprising cyclin inhibitor and preparation method thereof
JP2016513680A5 (enExample)
WO2012147101A3 (en) Pharmaceutical compositions of raltegravir, methods of preparation and use thereof
GEP201706743B (en) Oral formulation for the treatment of cardiovascular diseases
MX394413B (es) Composicion farmaceutica que contiene clomipramina y metodo de preparacion de la misma
MX361275B (es) Formulacion de capsula de acido 5-aminosalicilico.
MX2015009077A (es) Composicion estable que contiene fingolimod.
PH12014502170B1 (en) Drug composition and soft capsule drug sealing the drug composition